Among patients with high-risk muscle-invasive urothelial carcinoma, postsurgical Keytruda extended the time some lived ...

Disease-free survival is significantly longer with adjuvant pembrolizumab than observation among patients with high-risk ...

Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...

Enfortumab vedotin showed a robust disease control rate in patients with urothelial cancer outside of a clinical trial, and ...

This is the first comprehensive immunohistochemical analysis of the expression of several class I HDAC proteins (1, 2 and 3) in urothelial carcinoma. In our study, we found all three isoforms in a ...

Muscle-invasive urothelial carcinoma is an aggressive disease with high rates of relapse. Whether pembrolizumab as adjuvant therapy would be effective in patients with high-risk muscle-invasive ...

The regimen is intended for adults with unresectable or metastatic urothelial cancer who are eligible for platinum-containing chemotherapy.

Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...

The Metastatic Transitional (Urothelial) Tract Cancer drugs in development market research report provides comprehensive information on the therapeutics under development for Metastatic Transitional ...

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that three abstracts on BL-B01D1, a ...